Frontal Affinity Chromatography Coupled to Mass Spectrometry: An Effective Method for Kd Determination and Screening of α-Gal Derivatives Binding to Anti-Gal Antibodies (IgG)

Journal of Carbohydrate Chemistry

Volumn 22, Issue 6, 2003, Pages 347-376

  Wang, Jianqiang ^a,b,c   Zhang, Boyan ^a   Fang, Jianwen ^b   Sujino, Keiko ^a   Li, Hong ^a   Otter, Albin ^a   Hindsgaul, Ole ^a   Palcic, Monica M ^a   Wang, Peng George ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b WAYNE STATE UNIVERSITY   (United States)

^c Triad Therapeutics Inc   (United States)

Author keywords

Gal; Anti Gal antibody; Frontal affinity chromatography; Kd determination

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; CARBOHYDRATE DERIVATIVE; GALACTOSE; IMMUNOGLOBULIN ANTIBODY;

AFFINITY CHROMATOGRAPHY; ANALYTIC METHOD; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; ION PAIR CHROMATOGRAPHY; SCREENING TEST;

ANIMALIA;

EID: 0242460411     PISSN: 07328303     EISSN: None     Source Type: Journal    
DOI: 10.1081/CAR-120025323     Document Type: Article

References (79)

1. Platt, J.L. New directions for organ transplantation. Nature 1998, April, 392, 11, supplement.
2. Cooper, D.K.C.; Gollackner, B.; Knosalla, C.; Teranishi, K. Xenotransplantation-how far have we come? Transplant. Immunol. 2002, 9, 251.
3. Cascalho, M.; Platt, J.L. The immunological barrier to xenotransplantation. Immunity 2001, 14 (4), 437.
4. Galili, U. Interaction of the natural anti-gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol. Today 1993, 14, 480.
5. Cooper, D.K.C.; Koren, E.; Oriol, R. Oligosaccharides and discordant xenotransplantation. Immunol. Rev. 1994, 141, 31.
6. Platt, J.L. A perspective on xenograft rejection and accommodation. Immunol. Rev. 1994, 141, 127.
7. Sandrin, M.; McKenize, I.F.C. Galα1,3Gal, the major xenoantigen(s) recognized in pigs by human natural antibodies. Immunol. Rev. 1994, 141, 169.
8. Samuelsson, B.E.; Rydberg, L.; Breimer, M.E.; BÄcker, A.; Gustavsson, M.; Holgersson, J.; Karlsson, E.; Uyterwaal, A.-C.; Cairns, T.; Welsh, K. Natural antibodies and human xenotransplantation. Immunol. Rev. 1994, 141, 151.
9. Galili, U.; Tanemura, M. Significance of α-Gal (Galα1, 3Galβ1,4GlcNAc-R) epitopes and α1,3galactosyltransferase in xenotransplantation. Trends Glycosci. Glycotechnol. 1999, 11 (62), 317.
10. Galili, U. The α-gal epitope (Galα1,3Galβ1,4GlcNAc-R) in xenotransplantation. Biochimie 2001, 83 (7), 557.
11. Xu, Y.; Lorf, T.; Sablinski, T.; Gianello, P.; Bailin, M.; Monroy, R.; Kozlowski, T.; Awwad, M.; Cooper, D.K.C.; Sachs, D.H. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1,3Galβ1,4Glc-X immunoaffinity column. Transplantation 1998, 65 (2), 172.
12. Taniguchi, S.; Neethling, F.A.; Korchagina, E.Y.; Bovin, N.; Ye, Y.; Kobayashi, T.; Niekrasz, M.; Li, S.; Koren, E.; Oriol, R.; Cooper, D.K.C. In vivo immunpadsorption of anti-pig antibodies in baboons using a specific αGal1,3Gal column. Transplantation 1996, 62, 1379.
13. Kroshus, T.J.; Bolman, R.M.; Dalmasso, A.P. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation 1996, 62, 5.
14. Leventhal, J.R.; John, R.; Fryer, J.P.; Witson, J.C.; Derlich, J.-M.; Remiszewski, J.; Dalmasso, A.P.; Matas, A.J.; Bolman, R.M., III. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption: results of in vitro and in vivo studies. Transplantation 1995, 59 (2), 294.
15. 2, its linkage to activated matrices and absorption of anti-α-Gal xenoantibodies by affinity columns. Carbohydr. Res. 2000, 525 (4), 265.
16. Schroder, C.; Martin, U.; Simon, A.; Laaff, G.; Weibe, K.; Haverich, A.; Lapin, B.; Steinhoff, G. Discordant lung xenotransplantation using α-Gal columns, pig-kidney absorption, and complement depletion in baboons. Transplant. Proc. 2001, 33 (1-2), 738.
17. Dean, P.G.; Cohen, A.J.; Dalla Valle, H.; Grande, J.P.; Diamond, L.E.; Byrne, G.W.; Logan, J.S.; McGregor, C.G.A.; Stegall, M.D. The effect of anti-α-Gal antibody removal with immunoabsorption and splenectomy on CD46 transgenic kidney xenograft survival. Transplant. Proc. 2001, 33 (1-2), 721.
18. Simon, P.M.; Neethling, P.A.; Taniguchi, S.; Goode, P.I.; Zopf, D.; Hancock, W.W.; Cooper, D.K.C. Intravenous infusion of Galα1,3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 1998, 65 (3), 346.
19. Rieben, R.; Von Allmen, E.; Korchagina, E.Y.; Nydegger, U.; Neethling, F.A.; Kujundzic, M.; Koren, E.; Bovin, N.; Cooper, D.K.C. Detection, immunoadsorption, and inhibition of cytotoxic activity of anti-αGal antibodies using newly developed substances with synthetic Galα1-3Gal disaccharide epitopes. Xenotransplantation 1995, 2, 98.
20. Li, S.; Neethling, F.; Taniguchi, S.; Yeh, J.-C; Kobayashi, T.; Ye, Y.; Koren, E.; Cummings, R.D.; Cooper, D.K.C. Glycans derived from porcine stomach mucin are effective inhibitors of natural anti-α-galactosyl antibodies in vitro and after intravenous infusion in baboons. Transplantation 1996, 62 (9), 1324.
21. Magnusson, S.; Strokan, V.; Molne, J.; Nilsson, K.; Rydberg, L.; Breimer, M.E. Blocking of human anti-pig xenoantibodies by soluble Galα1,3Gal and Galα1-2Gal disaccharides; studies in a pig kidney in vitro perfusion model. Transpl. Int. 2000, 13 (6), 402.
22. Diamond, L.E.; Byrne, G.W.; Schwarz, A.; Davis, T.A.; Adams, D.H.; Logan, J.S. Analysis of the control of the anti-Gal immune response in a non-human primate by galactose α1,3galactose trisaccharide-polyethylene glycol conjugate. Transplantation 2002, 73 (11), 1780.
23. Brinkmann, N.; Malissard, M.; Ramuz, M.; Romer, U.; Schumacher, T.; Berger, E.G.; Elling, L.; Wandrey, C.; Liese, A. Chem-enzymatic synthesis of the Galili epitope Galα(1,3)Galβ(1,4)GlcNAc on a homogeneously soluble PEG polymer by a multi-enzyme system. Bioorg. Med. Chem. Lett. 2001, 11 (18), 2503.
24. Leventhal, J.R.; Dalmasso, A.P.; Cromwell, J.W.; Platt, J.L.; Manivel, C.J.; Bolman, R.M., III; Matas, A.J. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993, 55, 857.
25. Kobayashi, T.; Taniguchi, S.; Ye, Y.; Niekrasz, M.; Kosanke, S.; Neethling, F.A.; Wright, L.J.; Rose, A.G.; White, D.J.G.; Hancock, W.W.; Cooper, D.K.C. Delayed xenograft rejection in C3-depleted discordant (pig to baboon) cardiac xenografts treated with cobra venom factor. Transplant. Proc. 1996, 28, 560.
26. Leventhal, J.R.; Sakiyalak, P.; Whitson, J.; Simone, P.; Matas, A.J.; Bolman, R.M., III; Dalmasso, A.P. Synergistic effect of combined antibody and complement depletion upon discordant cardiac xenograft survival in non-human primates. Transplantation 1994, 57, 974.
27. Cozzi, E.; White, D.J.G. The generation of transgenic pigs as potential organ donors for humans. Nature (Med) 1995, 1, 964.
28. Cozzi, E.; Yannoutsos, N.; Langford, G.A.; Pinochavez, J.; Wallwork, J.; White, D.J.G. Effect of transgenic expression of human decay--accelerating factor on the inhibition of hyperacute rejection of pig organs. In Xenotransplantation, 2nd Ed.; Cooper, D.K.C., Kemp, E., Platt, J.L., White, D.J.G., Eds.; Springer: Berlin, 1997; 665.
29. McCurry, K.R.; Kooyman, D.L.; Alvarado, C.G.; Cotterell, A.H.; Martin, M.J.; Logan, J.S.; Platt, J.L. Human complement regulatory proteins protect swine to primate cardiac xenografts from human injury. Nature Med. 1995, 1, 423.
30. Thall, A.D.; Maly, P.; Lowe, J.B. Oocyte Galα1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 1995, 270, 21437.
31. Sandrin, M.S.; Fodor, W.L.; Mouhtouris, E.; Osman, N.; Cohney, S.; Rollins, S.A.; Guilmette, E.R.; Setter, E.; Squinto, S.P.; McKenzie, I.F.C. Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human-antibody binding and complement-mediated cytolysis. Nature Med. 1995, 7, 1261.
32. Koren, E.; Milotic, F.; Neethling, F.; Koscec, M.; Fei, D.; Kobayashi, T.; Taniguchi, S.; Cooper, D.K.C. Monoclonal anti-idiotypic antibodies neutralize cytotoxic effects of anti-αGal antibodies. Transplantation 1996, 62 (6), 837.
33. Koma, M.; Miyagawa, S.; Honke, K.; Nakai, R.; Miyoshi, S.; Ohta, M.; Matsuda, H.; Shirakura, R.; Taniguchi, N. The possibility of reducing xenoantigen levels with a novel Gal3′-sulfotransferase (GP3ST). J. Biochem. 2002, 131 (4), 517.
34. Liu, D.G.; Kobayashi, T.; Yokoyama, I.; Ogawa, H.; Nagasaka, T.; Muramatsu, H.; Kadomatsu, K.; Oikkawa, T.; Shimano, Y.; Morozumi, K.; Uchida, K.; Muramatsu, T.; Nakao, A. Enzymatic removal of α-Gal antigens in pig kidneys by ex vivo and in vivo administration of endo-β-galactosidase C. Xenotransplantation 2002, 9 (3), 228.
35. Miyagawa, S.; Tanemura, M.; Koyota, S.; Koma, M.; Ikeda, Y.; Shirakura, R.; Taniguchi, N. Masking and reduction of the galactose-α1,3-galactose epitope (α-Gal), the major xenoantigen in swine, by the glycosyltransferase gene transfection. Biochem. Biophys. Res. Commun. 1999, 264 (3), 611.
36. Tanemura, M.; Ogawa, H.; Yin, D.P.; Chen, Z.C.; DiSesa, V.J.; Galili, U. Elimination of anti-Gal B cells by α-Gal ricin. Transplantation 2002, 73 (12), 1859.
37. Tanemura, M.; Yin, D.; DiSesa, V.J.; Galili, U. Preventing anti-Gal response in xenograft recipients by an α-Gal toxin. Transplant. Proc. 2001, 33 (1-2), 699.
38. Itescu, S.; Minanov, O.P.; Michler, R.E. Xenotransplantation, 2nd Ed.; Cooper, D.K.C., Kemp, E., Eds.; Springer: Heidelberg, 1997; 478.
39. McKane, W.; Lee, J.; Preston, R.; Hacking, A.; Simpson, P.; Lynds, S.; Goldberg, L.; Cairns, T.; Tavbe, D. Polymorphism in the human anti-pig natural antibody repertoire. Transplantation 1998, 66 (5), 626.
40. Chen, X.; Zhang, J.; Kowal, P.; Liu, Z.; Andreana, P.R.; Lu, Y.; Wang, P.G. Transferring a biosynthetic cycle into a productive E. coli strain: large scale synthesis of galactosides. J. Am. Chem. Soc. 2001, 123, 8866.
41. Zhang, W.; Wang, J.; Li, J.; Yu, L.B.; Wang, P.G. Large scale synthesis of a derivative of an α-galactosyl trisaccharide epitope involved in the hyperacute rejection of Xenotransplantation. J. Carbohydr. Chem. 1999, 18, 1009.
42. Fang, J.; Li, J.; Xi, C.; Zhang, Y.; Wang, J.; Guo, Z.; Zhang, W.; Yu, L.; Brew, K.; Wang, P.G. A highly efficient chem.-enzymatic synthesis of α-galactosyl epitopes with a recombinant α1,3-galactosyltransferase. J. Am. Chem. Soc. 1998, 120, 6635.
43. Fang, J.; Chen, X.; Zhang, W.; Wang, J.; Andreana, P.R.; Wang, P.G. Chemoenzymatic synthesis of α-Gal epitope derivatives containing free amino groups: Efficient separation and further manipulation. J. Org. Chem. 1999, 64, 4089.
44. Vic, G.; Scigelova, M.; Hastings, J.J.; Howarth, O.W.; Crout, D.H.G. Glycosidase-catalysed synthesis of oligosaccharides: trisaccharides with the alpha-D-Gal-(1,3)-D-Gal terminus responsible for the hyperacute rejection response in cross-species transplant rejection from pigs to man. Chem. Commun. 1996, 1473.
45. Vic, G.; Tran, C.H.; Scigelova, M.; Crout, H.G. Glycosidase-catalysed synthesis of oligosaccharides: a one step synthesis of lactosamine and of the linear B type 2 trisaccharide alpha-D-Gal-(1,3)-beta-D-Gal-(1,4)-beta-D- GlcNAcSEt involved in the hyperacute rejection response in Xenotransplantation from pigs to man and as the specific receptor for toxin A from Clostridium difficile. Chem. Commun. 1997, 169.
46. Thiem, J.; Wiemann, T. Synthesis of galactose-terminated oligosaccharides by use of galactosyltransferase. Synthesis 1992, 141.
47. Gege, C.; Kinzy, W.; Schmidt, R.R. Total synthesis of the natural antigen involved in the hyperacute rejection response to xenotransplants. Carbohydr. Res. 2000, 328 (4), 459.
48. Yudina, O.N.; Sherman, A.A.; Nifantiev, N.E. Synthesis of propyl and 2-aminoethyl glycosides of α-D-galactosyl-(1,3)-β-lactoside. Carbohydr. Res. 2001, 332, 363.
49. Lu, Y.P.; Li, H.; Cai, M.S.; Li, Z.J. Synthesis of a divalent glycoside of an alpha-galactosyl disaccharide epitope involved in the hyperacute rejection of Xenotransplantation. Carbohydr. Res. 2001, 334 (4), 289.
50. Hanessian, S.; Saavedra, O.M.; Masciti, V.; Marterer, W.; Oehrlein, R.; Mak, C.P. Practical synthesis of B disaccharide and linear B type trisaccharide-non-promate epitope markers recognized by human anti-alpha-Gal antibodies causing hyperacute rejection of xenotransplants. Tetrahedron 2001, 57 (16), 3267.
51. Wang, J.-Q.; Chen, X.; Zhang, W.; Zacharek, S.; Chen, Y.; Wang, P.G. Enhanced inhibition of human anti-Gal antibody binding to mammalian cells by synthetic α-Gal epitope polymers. J. Am. Chem. Soc. 1999, 121, 8174.
52. Ghanekar, A.; Luo, Y.; Yang, H.; Garcia, B.; Luke, P.; Chakrabarti, S.; Lajoie, G.; Phillips, M.J.; Katopodis, A.; Cattral, M.S.; Wall, W.; Jevnikar, A.; Bailey, M.; Levy, G.A.; Grant, D.R.; Zhong, R. The α-Gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts. Transplant. Proc. 2001, 33 (7-8), 3863.
53. Byrne, G.W.; Schwarz, A.; Fesi, J.R.; Birch, P.; Nepomich, A.; Bakaj, I. ; Velardo, M.A.; Jiang, C.; Manzi, A.; Dintzis, H.; Diamond, L.E.; Logan, J.S. Evaluation of different alpha-galactosyl glycoconjugates for use in xenotransplantation. Bioconjug. Chem. 2002, 13 (3), 571.
54. Liu, B.; Roy, R. Synthesis of clustered xenotransplantation antagonists using palladium-catalyzed cross-coupling of prop-2-ynyl α-D- galactopyranoside. J. Chem. Soc., Perkin Trans. 1, 2001, 773-779.
55. Sashiwa, H.; Thompson, J.M.; Das, S.K.; Shigemasa, Y.; Tripathy, S.; Roy, R. Chemical modification of Chitosan: preparation and lectin binding properties of α-galactosyl-chitosan conjugates. Potential inhibitors in acute rejection following xenotransplantation. Biomacromolecules 2000, 1, 303-305.
56. Liu, B.; Roy, R. Olefin self-metathesis as a new entry into xenotransplantation antagonists bearing the Galili antigen. Chem. Commun. 2002, 594-595.
57. Galili, U.; Matta, K.L. Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides. Transplantation 1996, 62 (2), 256.
58. Schriemer, D.C.; Bundle, D.R.; Li, L.; Hindsgaul, O. Micro-scale frontal affinity chromatography with mass spectrometric detection: a new method for screening of compound libraries. Angew. Chem., Int. Ed. 1998, 37, 3383.
59. Zhang, B.; Palcic, M.M.; Schriemer, D.C.; Alvarez-Manilla, G.; Pierce, M.; Hindsgaul, O. Frontal affinity chromatography coupled to mass spectrometry for screening mixtures of enzyme inhibitors. Anal. Biochem. 2001, 299 (2), 173.
60. Zhang, B.; Palcic, M.M.; Mo, H.Q.; Goldstein, I.J.; Hindsgaul, O. Rapid determination of the binding affinity and specificity of the mushroom Polyporus aquamosus lectin using frontal affinity chromatography coupled to electrospray mass spectrometry. Glycobiology 2001, 11 (2), 141.
61. Arata, Y.; Hirabayashi, J.; Kasai, K. Application of reinforced frontal affinity chromatography and advanced processing procedure to the study of the binding property of a Caenorhabditis elegans galectin. J. Chromatogr., A 2001, 905 (1-2), 337.
62. Arata, Y.; Hirabayashi, J.; Kasai, K. Sugar binding properties of two lectin domains of the tandem repeat-type galectin LEC-1 (N32) of Caenorhabditis elegans--detailed analysis by an improved frontal affinity chromatography method. J. Biol. Chem. 2001, 276 (5), 3068.
63. Hirabayashi, J.; Arata, Y.; Kasai, K. Glycome project: concept, strategy and preliminary application to Caenorhabditis elegans. Proteomics 2001, 7 (2), 295.
64. Hirabayashi, J.; Kasai, K. Separation technologies for glycomics. J. Chromatogr., B 2002, 771 (1-2), 67.
65. Schriemer, D.C.; Hindsgaul, O. Deconvolution approaches in screening compound mixtures. Comb. Chem. High Throughput Screen. 1998, 1, 155.
66. Galili, V.; Clark, M.R.; Shohet, S.B.; Buehler, J.; Macher, B.A. Evolutionary relationship between the natural anti-Gal antibody and the Galα1,3Gal epitope in primates. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 1369.
67. Galili, V.; Shohet, S.B.; Kobrin, E.; Stolts, C.L.M.; Macher, B.A. Man, apes, and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J. Biol. Chem. 1988, 263, 17755.
68. McMorrow, I.M.; Comrack, C.A.; Sachs, D.H.; Dersimonia, H. Heterogenity of human anti-pig natural antibodies cross-reactive with the Gal(α1,3)galactose epitope. Transplantation 1997, 64 (3), 501.
69. David, S.; Thieffy, A.; Veyrieres, A. A mild procedure for the regiospecific benzylation and allylation of poly-hydroxy-vompoinds via their stannylene derivatives in non-polar solvents. J. Chem. Soc., Perkin Trans. 1 1982, 1796.
70. Unverzagt, C.; Kunz, H. Synthesis of glycopeptides and neoglycopeptides containing the fucosylated linkage region of N-glycoproteins. Bioorg. Med. Chem. 1994, 2, 1189.
71. Lönn, H. Synthesis of a tri-and a heptasaccharide which contain α-L-fucopyranosyl groups and are part of the complex type of carbohydrate moiety of glycoproteins. Carbohydr. Res. 1985, 139, 105.
72. 3 analogue. Carbohydr. Res. 1997, 301, 1.
73. Eckhardt, A.E.; Goldstein, I.J. Isolation and characterization of a family of alpha-D-galactosyl-containing glycopetides from ehrlich ascites tumor-cells. Biochemistry 1983, 22, 5290.
74. 1H NMR spectroscopy. Biochem. Biophys. Res. Commun. 1984, 122 (2), 859.
75. Santer, U.V.; Desantis, R.; Hard, K.J.; vanKvik, J.A.; Vligenthart, J.F.G.; Won, B.; Glick, M.C. N-linked oligosaccharide changes with oncogenic transformation require sialylation of multiantennae. Eur. J. Biochem. 1989, 181, 249.
76. Tamvra, T.; Wadhwa, M.S.; Rice, K.G. Reducing-end modification of N-linked oligosaccharides with tyrosine. Anal. Chem. 1994, 216, 335.
77. Rice, K.G.; Corradi Da Silva, M. Preparative purification of tyrosinamide N-linked oligosaccharides. J. Chromatogr. 1996, 720, 235.
78. Stubbs, H.J.; Shia, M.A.; Rice, K.G. Preparative purification of tetraantennary oligosaccharides from human asialyl orosomucoid. Anal. Chem. 1997, 247, 357.
79. X derterminants: clustered glycosides for studying selectin interactions. Carbohydr. Res. 1998, 306, 387.